Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update-Reference-Cited by-同舟云学术

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update

Published:2020-08-31 Issue:22 Volume:63 Page:13228-13257
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wu Tizhi¹,Qin Zhen¹,Tian Yucheng¹,Wang Jubo¹,Xu Chenxi¹,Li Zhiyu¹^ORCID,Bian Jinlei¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, People’s Republic of China

Funder

Ministry of Education of the People's Republic of China

Jiangsu Provincial Department of Education

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

State Key Laboratory of Drug Research

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00744

Reference140 articles.

1. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

2. Recent advances on CDK inhibitors: An insight by means of in silico methods

3. Signaling Pathways that Control Cell Proliferation

4. BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application

5. Cell Cycle Regulation by Checkpoints

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Discovery of novel CDK9 inhibitor with tridentate ligand: Design, synthesis and biological evaluation;Bioorganic Chemistry;2024-09

3. Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity;European Journal of Medicinal Chemistry;2024-09

4. Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological Malignancies;Journal of Medicinal Chemistry;2024-08-23

5. Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations;Journal of Molecular Modeling;2024-07-16